Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,400 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 5 February 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download: 

(PDF, 3MB, 197 pages)

 

Export 7 results:
Author Title [ Type(Desc)] Year
Filters: Author is Wallenhorst, C.  [Clear All Filters]
Journal Article
V. Cairns, Wallenhorst, C., Rietbrock, S., and Martinez, C., Incidence of Lyme disease in the UK: a population-based cohort study, BMJ Open, vol. 9, p. e025916, 2019.
C. Martinez, Wallenhorst, C., McFerran, D., and Hall, D. A., Incidence rates of clinically significant tinnitus: 10-year trend from a cohort study in England, Ear Hear, vol. 36, pp. e69-75, 2015.
T. S. Field, Weijs, B., Curcio, A., Giustozzi, M., Sudikas, S., Katholing, A., Wallenhorst, C., Weitz, J. I., Cohen, A. T., and Martinez, C., Incident Atrial Fibrillation, Dementia and the Role of Anticoagulation: A Population-Based Cohort Study, Thromb Haemost, 2019.
C. Martinez, Katholing, A., Wallenhorst, C., Granziera, S., Cohen, A. T., and Freedman, S. B., Increasing incidence of non-valvular atrial fibrillation in the UK from 2001 to 2013, Heart, vol. 101, pp. 1748-54, 2015.
C. Martinez, Wallenhorst, C., Rietbrock, S., and Freedman, B., Ischemic Stroke and Transient Ischemic Attack Risk Following Vitamin K Antagonist Cessation in Newly Diagnosed Atrial Fibrillation: A Cohort Study, J Am Heart Assoc, vol. 9, p. e014376, 2020.
C. Martinez, Katholing, A., Wallenhorst, C., and Cohen, A. T., Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients, Br J Haematol, 2020.
C. Martinez, Katholing, A., Wallenhorst, C., and Freedman, S. B., Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study, Thromb Haemost, vol. 115, pp. 31-9, 2016.
[Page last reviewed 5 February 2020]